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Background: Pseudomonas aeruginosa in the sinuses plays a role in the lungs in cystic fibrosis (CF) patients, but little is known about the sinus
environment where the bacteria adapt. Anoxic areas are found in the lower respiratory airways but it is unknown if the same conditions exist in the
sinuses.
Methods: The oxygen tension (pO2) was measured, using a novel in vivo method, in the maxillary sinus in a group of 20 CF patients.
Results: The CF patients had a significant lower pO2 on the mucosa but not in the sinus lumen as compared with a control group of non-CF
patients. Anoxic conditions were found in 7/39 (18%) of the sinuses from where we cultured P. aeruginosa, Stenotrophomonas maltophilia and/or
coagulase negative staphylococci.
Conclusion: These findings support our hypothesis that P. aeruginosa can adapt or acclimate to the environment in the lungs, during growth in
anoxic parts of the paranasal sinuses.
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Cystic fibrosis (CF) is a genetic disease caused by mutations
in the gene for the CF transmembrane conductance regulator
(CFTR) protein, resulting in altered chloride transport, in mul-
tiple organs, which comprises the mucociliary function and
renders the mucus viscosity and the mucosa more susceptible
to infections [1]. Nasal and sinus inflammation is a frequent
condition in patients with CF, commonly leading to findings
as congestion, mucopurulent material in the nose cavity, pol-⁎ Corresponding author. Department of Otolaryngology – Head & Neck
Surgery, Rigshospitalet, F2071, Copenhagen University Hospital, Blegdamsvej
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doi:10.1016/j.jcf.2010.12.002yposis, abnormalities of the lateral nasal wall, mucoceles, and
hypoplasia of the paranasal sinuses [2]. Such conditions might
affect the O2 exchange and the O2 content in the sinuses and
thus the microenvironment of its bacterial community.
The gas exchange in the maxillary sinus takes place via the
ostium and the mucosa that absorbs and consumes O2. The
diffusion through the ostium obeys simple physical laws and
depends on the patency of the ostium, the volume of the sinus
and the respiratory work in the nose.
The absorption of O2 from the sinuses as well as the change
in the O2 content in the paranasal sinuses after obstruction of the
ostium, are thought to be important factors in the pathogenesis
of sinusitis. There is a significant decrease in the luminal O2
content in persons with acute sinusitis or allergic rhinitis com-
pared with patients without symptoms [3,4]. Aust and Drettner
[4] also found decreased O2 tension (pO2) in a group of patientsd by Elsevier B.V. All rights reserved.
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obstructed ostia (all non-CF). They did not find pO2 to be
related to the presence or absence of antral pus or mucus.
Carenfelt and Lundberg [5] reported a pO2 close to zero in some
purulent sinus secretions with Streptococcus pneumoniae or
Haemophilus influenza compared with 96 mmHg in non-
purulent secretions. They conclude that the gas composition
in the sinuses influences the bacterial growth, as well as the
bactericidal function of the granulocytes, and that the O2
levels also might be of importance to the mucociliary activity.
Purulent sinusitis should thus be treated by drainage of the sinus
cavity, not only to reduce the debris, but also to improve the
condition for the local host defense mechanisms of the sinus.
The limited research that has been published regarding pO2
in the sinus deals with non-CF patients. CF patients have a
different inflammatory response in their sinus mucosa as com-
pared with non-CF related rhinosinusitis [6,7], and the O2
conditions and their importance for rhinosinusitis in these
patients are unknown. However, it has been shown that hypoxia
contributes to a reduction of cell surface CFTR [8], which might
have an additional negative impact in the sinuses of CF patients.
Chronic Pseudomonas aeruginosa lung infection develops
in most patients with CF. Once the bacteria have established
a chronic infection in the lungs, they cannot be eradicated.
P. aeruginosa is a facultative anaerobe, which can proliferate
and adapt to anaerobic environments, when thick layers of
mucoid exopolysaccharide surround the bacteria (biofilm).
Such biofilms are known to exist in the sinuses [6] and in
the lungs, and the presence of such biofilms limit the diffusive
supply of O2 which then can lead to total O2 depletion in
the sputum [9]. In addition, numerous of polymorphonuclear
leucocytes (PMNs) in the infected bronchi exhibit strong con-
sumption of O2 for production of reactive oxygen species
(ROS) [9–13].
Under such anoxic conditions P. aeruginosa can achieve
anaerobic growth either based on denitrification using nitrate
as a terminal electron acceptor or by fermentation of arginine
[9–12,14].
It has been indicated that P. aeruginosa responds to hypoxic
mucus with an upregulation of alginate production, which may
decrease the susceptibility to some antibiotics. Also, novel
therapies for CF include removal of hypoxic mucus plaques and
the use of antibiotics effective against P. aeruginosa adapted
to anaerobic environments [10].
In the mucus with low pO2, P. aeruginosa can make
alterations due to mutations caused by the ROS or conversion in
phenotype, e.g. becoming mucoid and developing antibiotic
resistance, in order to adapt to different focal niches [15,16].
Studies of P. aeruginosa suggest a correlation between nutrient
limitation, growth rates and conversion to mucoidy [17], and
we speculate that the same applies for anoxic conditions.
The upper airways are shown to be a gateway for acquisi-
tion of opportunistic bacteria like P. aeruginosa, where the
paranasal sinuses can act as a reservoir. Concordant genotypes
have been found in the sinuses and in the lungs [18]. Our
hypothesis is that P. aeruginosa adapts to the environment in
the paranasal sinuses where some bacteria mutate or conversetheir phenotype [19]. This results in bacterial strains that are fit
for spreading to the lungs, where they can maintain an ongoing
deleterious infection.
Our present knowledge about P. aeruginosa is primarily
related to the lungs. The pattern of inflammation differs in
the sinus from the findings in the lower airway specimens
of chronically infected patients with CF [20]. There is a Th2
dominated response in the lungs, while there is a significantly
reduced PMN response in the sinuses, probably due to the
higher concentration of IgA in the sinuses then in the lungs
[21]. The latter statement combined with the fact that anti-
biotics more difficultly penetrates and achieves therapeutic
levels in the sinus cavity than in the lungs, are some of the
reasons why the immune response in the sinuses is less chal-
lenging than in the lungs. Based on the above mentioned
knowledge, it is important to determine whether P. aeruginosa
can adapt to anaerobic environments in the sinuses. In this
study we determined the pO2 in the maxillary sinuses in CF
patients never infected, intermittently infected and chronically
infected with P. aeruginosa in their lungs as a first step towards
determining under which conditions P.aeruginosa adapts in
the sinuses.
2. Materials and methods
The patients were recruited at the CF Centre in Copenhagen.
The CF-diagnosis was based on characteristic clinical features,
abnormal sweat electrolytes and the genotype. CF patients
planned for sinus surgery were invited to participate in our
study. As a control group, we asked non-CF patients who
underwent surgery under general anesthesia because their nasal
septum needed correction. Patients suffering of acute or chronic
rhinosinusitis were excluded from the control group. All invited
CF-patients accepted to be included in the study, while two
patients who were invited to join the control group denied.
The CF-patients follows a routine with monthly medical
examinations including lung function tests and cultures taken
from the lower airways. At least every third month blood
samples are taken for measurements including antibodies
against P. aeruginosa (precipitating antibodies).
No standardized guidelines comprising criteria and motiva-
tions for sinus surgery in CF patients exist [22]. At our insti-
tution we select patients based on the following criteria in
descending order:
1. Patients with declining lung function despite intensive
antibiotic-chemotherapy and/or increasing antibodies against
Gram-negative bacteria despite negative bacteriology in their
sputum samples. Especially patients with unknown focus and
increasing antibodies against P. aeruginosa, Achromobacter
xylosoxidans or Burkholderia multivorans are given priority.
The majority of patients has been operated due to criteria 1,
but may also fulfill criteria 2 or 3 as well.
2. Patients who have undergone lung transplantation within the
last year.
3. Patients with severe symptoms of rhinosinusitis according to
EPOS guidelines [22].
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All the measurements were done during anesthesia, which
the patients underwent for other reasons. The measurements
were done through the natural ostia to the maxillary sinus, so no
permanent damage was done to the control group, and the CF
patients all had their sinuses opened during surgery afterwards.
The study was approved by the local ethics committee (H-A-
2008-141), and all patients gave informed consent. In patients
b18 years of age, consent was also obtained from their parents.
2.2. Preparation of optodes
The pO2 in the sinus was measured with a new type of
catheter O2 optode. See [23] for a recent review of fiber-optic
O2 sensor technology. The optode was manufactured from an
Endonasal Suction Tip (EST)(Medioplast, Malmö, Sweden,
3.0×150 mm 11 G) and a 3 m length of a plastic PMMA optical
fiber (POF, step index, 2 mm diameter with a polymethyl
methacrylate core and a fluorinated polymer cladding; Laser
Components GmbH, Olching, Germany). The end of the
POF was glued inside the EST with two components Super
Epoxy (Plastic Padding, Henkel Technologies) with ~1 mm
protruding from the tip of the EST. The other part was covered
with 2.4 mm shrink tubing (Low Shrink Temperature (LSTT)
polyolefin tubing; RS Components, Denmark) and a SMA-
connector (Laser Components GmbH, Germany, SMA-B2100)
was glued at the end. Both ends were subsequently polished
down to the metal. At the EST end, a disc (2 mm diameter) of
a 0.125 mm thick transparent Mylar®-foil (Goodfellow, UK)
was glued on the fiber tip with 1:1 diluted contact glue (Bostik
Kontaktlim A3). Subsequently, the foil was covered with a
thin layer of a luminescent O2 indicator layer composed of a
solution of 1 g polystyrene (Goodfellow), 500 mg TiO2, and
25 mg Pt(II) meso Tetra(pentafluorophenyl)porphine (PtTFPP)
(Frontier Scientific, USA), in 29 g CHCl3.
3. Calibration and measurements
Prior to use, the catheter O2 optodes were sterilized in a
plasma oven (Sterrad 100 S), which enables sterilization at low
temperatures using hydrogen peroxide. Calibration and mea-
surements were done with the catheter O2 optodes connected
to a fiber-optic O2 meter (Fibox 3, Minisensor Oxygen Meter,
Presens Precision Sensing GmbH, Regensburg, Germany)[24].
The optode meters used in this study measures the luminescence
lifetime with a phase-modulation technique [22], where the O2
dpendent luminescence lifetime of the PtTFPP indicator, τ, can
be calculated from the measured phase angle shift, Φ, between
the sinusoidal intensity modulated (at frequency, fmod) exci-
tation and emission signals:tan(Φ)=2π ⋅ fmod ⋅τ
The sensor response can be described by a modified Stern-
Volmer equation (x):
tanðΦÞ = tanðΦ0Þ 1−α1þKSV O2½  + α
 
ð1Þwhere, Ф0 is the phase angle of the indicator in the absence
of O2, Φ is the phase angle of the indicator at a given O2
concentration, KSV is a characteristic temperature dependent
quenching coefficient of the immobilized indicator, and α is the
non-quenchable fraction of the indicator (α=0.11 in this study)
in the carrier foil. For a given mixture of indicator and matrix
material, α is usually constant over the dynamic range (x). The
Stern-Volmer constant (Ksv) was calculated from calibration
values measured in anoxic and atmospheric air. The Φ0 was
measured in an anoxic bench and the ΦSat was measured in a
thermostated climate room with atmospheric air temperature of
37 °C. The values were not corrected for air pressure:
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3.1. Measurement
The patients (CF and non-CF) were anaesthetized using an
oral tracheal tube and intravenous solutions. The patients were
pre-oxygenated with 100% O2 before intubation. We waited
at least 15 min before onset of the O2-measurements. During
anesthesia, all patients were given ~40% O2 of supplementary
O2. At the beginning of the general anesthesia but prior to
surgery the catheter was introduced, through the nasal cavity,
into the maxillary sinus through the natural maxillary ostium
(Figs. 1 and 2). The pO2 in the maxillary sinuses was con-
tinuously recorded, first in the lumen of the sinus, and then
with the catheter touching the mucosa in the bottom of the
sinus. It was noted if the patient had an occluded or a patent
maxillary ostium. Temperature, pH and the volume of the
sinuses were not recorded. After the pO2 was measured, a
regularly sinus surgery was performed, where each maxillary
sinus was cultured separately.
All CF patients were CT scanned within 6 weeks prior to
surgery and staged according to the Lund McKay staging
system, where every sinus scores from 0 (no opacification) to 2
(total opacified).
3.2. Statistical methods and definitions
Statistical significance was evaluated by unpaired t-test for
observations with parametric data. Catagorical data were
analysed by Fisher's exact test. A p-valueb0.05 was considered
statistically significant. The tests were performed with Prism
4.0c (GraphPad Software, La Jolla, California, USA).
We define anoxia as pO2 valuesb0.8 mmHg.
Fig. 1. The catheter with the incorporated optode.
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4.1. Patients
The pO2 was measured in 20 CF patients, representing 39
maxillary sinuses (one measurement failed). The mean age
of the CF patients was 18 years (range 6–39 years.), 12 of the
patients were under 18 years of age. One patient had previously
undergone sinus surgery but his ostia to the maxillary sinuses
were totally obstructed.
Sixteen of the 20 CF patients were categorized as intermit-
tently infected [25], two were chronically infected and two were
lung transplanted (former chronically P.aeruginosa infected).
Four out of 40 CF-sinuses had a Lund McKay score [26] of 0
(no opacification) seen on the CT scan. The average score of all
sinuses was 1.2. The control group contained 11 patients
representing 22 sinuses. The mean age was 31 years ( range 22–
66 years.)Fig. 2. The catheter on its way t4.2. Microbiology
In nine CF-patients representing 13 sinuses, mucoid and/or
non-mucoid P. aeruginosa were found. In only one maxillary
sinus no bacteria were detected. Besides P. aeruginosa, the
results from the cultivation were as follows: 3 sinuses contained
Stenotrophomonas maltophilia, 3 A. xylosoxidans, 23 coagulase
negative staphylococci (CNS), 3 Staphylococcus aureus, 3
Haemophilus influenzae, 1 Enterobacter cloacae and 3 sinus
contained Candida albicans. (Several sinuses had growth of
more than one microorganism).
4.3. pO2 measurements
A significantly (pb0.03) lower pO2 on the maxillary mucosa
was found in CF patients, as compared with the control group
(Fig. 3). There was no difference between the patients above
and under 18 years of age within the CF group.o the right maxillary sinus.
Fig. 3. PO2 on the mucosa of all maxillary sinuses (t-test) Pb0.0263.
Fig. 4. A typical coronal CT scan of a CF patient. A right total opacified
maxillary sinus is seen. The left maxillary sinus shows a little air (black)
medially in the top between the natural ostium and the middle turbinate.
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measurements in the lumen of the sinuses below 20 mmHg O2
(10.0 and 13.8 mmHg) and none with an anoxic lumen. There
was no correlation between the types of bacteria cultured from
the sinuses, the presence of pus or visible enlarged ostia, or
the pO2 content in the maxillary lumen. The pO2 was not
significantly lower in the CF patients' lumen compared to the
controls either.
We found anoxic conditions on the mucosa in five CF-
patients, comprising three patients with unilateral anoxia and
two patients with bilateral anoxia. Thus, anoxia was found at a
higher frequency in the CF patients than in non-CF patients
(pb0.02). Four of the sinuses harbored P. aeruginosa and/or S.
maltophilia but we also diagnosed total anoxia in three sinuses
that only harbored CNS.
In eight sinuses in five patients no macroscopically pus was
found. These sinuses were not anoxic. However, we also found
high pO2 in sinuses with pus and P. aeruginosa.
In three sinuses from three patients a large visible natural
ostium to the maxillary sinus existed in accordance with high
pO2 values in the lumen (average of 128.3 mmHg). Unexpect-
edly, anoxia on the mucosa was demonstrated in one of
these patients. No significant difference was found between the
luminal pO2.
5. Discussion
Little is known about how O2 influences the immune system
and the bacterial community in the sinuses, and to our knowl-
edge no research has previously been done in relation to either
the pO2 lumen or the pO2 mucosa in the sinuses of CF patients.
We found a significantly lower pO2 on the mucosa in CF
patients than in the healthy control group, and also found someCF patients with anoxic conditions. However, we suspect that
our study has a tendency to overestimate the pO2 values. The
reasons are: 1: If the sensitive optode comes in contact with a lot
of blood it will measure the pO2 in the blood; 2: The fact that all
patients were given supplementary O2 which could increase the
pO2 in the sinuses; 3: We only measured a little area in the
bottom of the sinus mucosa, from which we cannot exclude the
possibility that other areas of the mucosa had lower or higher
pO2. Our measurements were done in the maxillary sinuses,
but we expect our findings to be representative for the other
paranasal sinuses as well.
No follow up study was made, but additional measurements
in patients with anoxic conditions could have determined
whether the pO2 increased after surgery. In principle, it is
possible to re-measure some patients only using local anes-
thetics, as long as the sinus ostium exceeds 4 mm and the patient
is capable of lying still for about two minutes while the optode
is in contact with the mucosa. Due to unfortunate circumstances
as severe nasal septum deviation, young age, and two patients
dropping out of our follow up study, we have not, so far, had
patients for re-measuring their pO2.
The CF-sinus-anatomy varies, probably due to the associated
chronic rhinosinusitis when the sinus development takes place.
Consequently the natural maxillary ostium is often obstructed.
However, among the minority a very enlarged ostium is ob-
served. Opacified (blurred) sinuses and viscous mucus compli-
cates the O2 diffusion in the sinuses (Fig. 4). CF patients often
have opacified sinuses diagnosed by a CT-scan. In physical
examination or during sinus surgery, the nose and sinuses
often present clinical signs of inflammation and infection, but
this is less commonly related to rhinosinusitis symptoms than
in non-CF patients. We have shown somemaxillary sinuses with
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that some sinuses may contain aerobic as well as anaerobic areas,
probably hosting two different niches of P.aeruginosa, as seen
in CF-sputum [9], which could enter the lower airways. In the
anoxic areas, we suspect a lower growth rate and an adaption to
the environment as seen in the endobronchial mucus [9]. Our
bacterial findings and the observed O2 depletion confirms that P.
aeruginosa, as well as other bacteria, can adapt to and live under
anaerobic conditions in the maxillary sinuses. We suspect that
the sinus epithelium, the bacteria and the PMNs along with other
inflammatory mechanisms competes to use the limited amount
of O2. These results support the hypothesis that P. aeruginosa
can adapt to and change phenotype in the sinuses where there is
O2 depletion, a lover antibiotic concentration and a less active
immune system/PMN response than in the lungs.
No significant difference was found in the lumen pO2, which
we suspect is due to O2 consumption primarily taking place
in the mucus/mucosa, and due to the fact that O2 in the lumen
represent a large O2 reservoir compared with the mucus,
wherein O2 is less soluble as in air. Full depletion of lumen O2 is
thus unlikely.
No correlation between the pO2 values on the left and right
sinuses was shown. This compares with the fact that we often
found different microbiological flora in the two maxillary
sinuses, and that the anatomic findings in the two sides often
differ. This supports the theory that bacteria, the size of the
sinus, and the size of the ostium influence the pO2.
Since the function of the CFTR gene is reduced by hypoxia
[8] and because it has been suggested that the immune system is
less functional in O2 depleted areas [5], we speculate whether
anoxia itself should be an indication for sinus surgery, and if
harmless bacteria, such as CNS, can induce unfavorable con-
ditions with anoxic pus. We have not been able to show a
significant difference between the pO2 in the maxillary lumen,
but we hypothesize that surgery gives the possibility for sinus
irrigations with saline and antibiotics and hence a better pO2
besides the removal of pus and bacteria.
6. Conclusion
We present a new method for determining the pO2in the
maxillary sinuses. In this first study, it was only used during
sinus surgery, but the new method can, in some cases, be used
after surgery without anesthesia. We show that patients with CF
have a lower pO2 on the mucosa as compared to a control group.
Some CF patients have anoxic conditions, probably due to the
mucosa's and the bacteria's O2 consumption. In contrast, there
was no anoxia in the sinus lumen. Both P. aeruginosa and
CNS can thrive under anoxic conditions in the sinuses. These
findings support our hypothesis that P. aeruginosa can adapt to
the environment, mutate or converse phenotype in the paranasal
sinuses. In addition, hypoxia influences the regulation of the
CFTR protein, may facilitate biofilm formation and may in-
fluence the immune system. It is not known, whether surgery
alone improves the anoxia in the mucosa, but surgery is often
necessary if one should attempt to remove the anoxic secretions
buy suction and nasal irrigations.Acknowledgements
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